STAT+: Hospitals earn big profits, insurers face ramped up Medicare Advantage audits
STAT
MAY 27, 2025
Continue to STAT+ to read the full story…
2025 Documentation Drug Pricing 
240 
STAT+: Senators delay start date for possible PBM reforms
STAT
MAY 1, 2023
Senators drafting reforms to the drug middlemen industry have delayed their effective date by at least 10 months, according to new documents obtained by STAT. The original date that pharmacy benefit manager reforms were supposed to take effect was Jan.
Join 11,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Navigating 340B Program Changes in 2025
Proxsys Rx
APRIL 1, 2025
The situation may worsen if more drug companies follow suit in restricting 340B savings. As we enter 2025 Q2, the sad truth is that most 340B hospitals are struggling to protect their programs from further prescription-savings erosion. Automate your 340B program with customized software streamlining documentation and reporting.
NHC Comments on IRA Guidance Response
Putting Patients First Blog
APRIL 14, 2023
The NHC also requests that CMS highlight when and how the agency removed QALY-based metrics from consideration in MFP justification documentation. Created by and for patient organizations over 100 years ago, the NHC brings diverse organizations together to forge consensus and drive patient-centered health policy.
Pharma in Brief’s 2023 Year in Review and Trends for 2024
Pharma in Brief
JANUARY 10, 2024
Expected highlights for 2024 include a final PTA regime, more details on PMPRB drug pricing guidelines and national pharmacare, and fall-out from the US mass drug importation program targeting Canadian medicines. The amendments are scheduled to come into force no later than January 1, 2025. Regulatory changes.
How Recent 340B Changes Impact Specialty Pharmacies In 2025
Proxsys Rx
JUNE 4, 2025
The evolving legal and legislative landscape surrounding the 340B Drug Pricing Program has significant implications for hospitals’ specialty pharmacies. Two key 340B legal cases: There have been two very closely-watched federal court cases that address the ongoing dispute between drug manufacturers and the U.S.
Follow the 340B Prescription Dollar: How PBMs Profit from 340B Contract Pharmacies (rerun)
Drug Channels
DECEMBER 11, 2024
This week, Im rerunning some popular posts while I prepare for Fridays Drug Channels Outlook 2025 live video webinar. Click here to see the original post. In the video excerpt below, I walk through a brief history of 340B contract pharmacies.
Let's personalize your content